Clostridium difficile-associated diarrhea and colitis: Clinical manifestations, diagnosis, and treatment

Diseases of the Colon and Rectum

Volumn 41, Issue 11, 1998, Pages 1435-1449

  Cleary, Robert K ^a  

^a ST JOSEPH MERCY HOSPITAL   (United States)

Author keywords

Antibiotic associated colitis; Clostridium difficile; Nosocomial infection; Pseudomembranous colitis

Indexed keywords

ANTITOXIN; IMMUNOGLOBULIN G; METRONIDAZOLE; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; CLOSTRIDIUM DIFFICILE; COLITIS; COLON RESECTION; DIAGNOSTIC ACCURACY; DIARRHEA; DISEASE ASSOCIATION; DISEASE CARRIER; ENDOSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEALTH CARE COST; HOSPITAL INFECTION; HUMAN; ILEOSTOMY; PATHOGENESIS; TOXIC MEGACOLON; TREATMENT PLANNING;

EID: 0031742216     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02237064     Document Type: Article

References (110)

1. Bartlett JG, Chang TW, Gurwith M, Gorbach SL, Onderdonk AB. Antibiotic associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med 1978;298:531-4.
2. Finney JM. Gastroenterostomy for cictratizing ulcer of the pylorus. Bull Johns Hopkins Hosp 1893;4:53-5.
3. Tedesco FJ, Stanley RJ, Alpers DH. Diagnostic features of clindamycin-associated pseudomembranous colins. N Engl J Med 1974;290:841-3.
4. Jobe BA, Grasley A, Deveney KE, Deveney CW, Sheppard BC. Clostridium difficile colitis: an increasing hospital-acquired illness. Am J Surg 1995;169:480-3.
5. Altmeier WA, Hummel RP, Hill EO. Staphylococcal enterocolitis following antibiotic therapy. Ann Surg 1963;157:847-58.
6. Marr JJ, Sans MD, Tedesco FJ. Bacterial studies of clindamycin-associated colitis. Gastroenterology 1975;69:352-8.
7. Rolfe RD, Helebian S, Finegold SM. Bacterial interference between Clostridium difficile and normal fecal flora. J Infect Dis 1981;143:470-5.
8. Worden JP. Pharmacotherapy: Management of Clostridium difficile colitis. Curr Surg 1996;53:46-50.
9. Tabaqchali S, Jumaa P. Diagnosis and management of Clostridium difficile infection. BMJ 1995;310:1375-80.
10. Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. N Engl J Med 1992;330:257-62.
11. Bradbury AW, Barrett S. Surgical aspects of Clostridium difficile colitis. Br J Surg 1997;84:150-9.
12. Goodman LJ, Harris AA. Clostridium difficile: A review of recent advances in diagnosis, treatment, and prevention. J Nosoc Infect 1985;4:24-8.
13. Kabins SA, Spira TJ. Outbreak of clindamycin-associated colitis. Ann Intern Med 1975;83:830-1.
14. Bartlett JG. Clostridium difficile infection: pathophysiology and diagnosis. Semin Gastrointest Dis 1997;8:12-21.
15. Viscidi R, Willey S, Bartlett JG. Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations. Gastroenterology 1981;81:5-9.
16. Larson HE, Barclay FE, Honour P, Hill ID. Epidemiology of Clostridium difficile in infants. J Infect Dis 1982;146:727-33.
17. Marts BC, Longo WE, Vernava AM III, Kennedy DJ, Daniel GL, Jones I. Patterns and prognosis of Clostridium difficile colitis. Dis Colon Rectum 1994;37:837-45.
18. Wilcox MH. Cleaning up Clostridium difficile infection. Lancet 1996;348:767-8.
19. Anand A, Bashey B, Mir T, Glatt AE. Epidemiology, clinical manifestations, and outcome of Clostridium difficile associated diarrhoea. Am J Gastroenterol 1994;89:519-23.
20. Keighley MR. Antibiotic-associated pseudomembranous colitis: pathogenesis and management. Drugs 1980;20:49-56.
21. Gerding DN, Olson MM, Peterson LR, et al. Clostridium difficile-associated diarrhea and colitis in adults: a prospective case-controlled epidemiologic study. Arch Intern Med 1986;146:95-100.
22. Talbot RW, Walker RC, Heart RW Jr. Changing epide-miology, diagnosis, and treatment of Clostridium difficile toxin-associated colitis. Br J Surg 1986;73:3:457-60.
23. Medich DS, Lee KK, Simmons RL, Grubbs PE, Yang HC, Showalter DP. Laparotomy for fulminant pseudomembranous colitis. Arch Surg 1992;127:847-52.
24. McFarland LV, Mulligan ME, Kwok RY, Stamm WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989;320:204-10.
25. Fekety R. Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. Am J Gastroenterol 1997;92:739-50.
26. Gerding DN. Is there a relationship between vancomycin-resistant enterococcal infection and Clostridium difficile infection? Clin Infect Dis 1997;25(Suppl 2):206-10.
27. Riley TV, Cooper M, Bell B, Golledge CL. Community-acquired Clostridium difficile-associated diarrhea. Clin Infect Dis 1995;20(Suppl 2):263-5.
28. Gerding DN, Olson MM, Johnson S, Peterson LR, Lee JT Jr. Clostridium difficile diarrhea and colonization regimens after treatment with abdominal infection containing clindamycin or metronidazole. Am J Surg 1990;159:212-7.
29. Chen FC, Woods R. Pseudomembranous panenteritis and septicaemia in a patient with ulcerative colitis. Aust N Z J Surg 1996;66:565-7.
30. Trevisani F, Simoncini M, Alampi G, Bernardi M. Colitis associated to chemotherapy with 5-fluorouracil. Hepatogastroenterology 1997;44:710-2,
31. Yee J, Dixon CM, McLean AP, Meakins JL. Clostridium difficile disease in a department of surgery: the significance of prophylactic antibiotics. Arch Surg 1991;126:241-6.
32. Fekety R, Shah AB. Diagnosis and treatment of Clostridium difficile colitis. JAMA 1993;269:71-5.
33. Settle CD. Clostridium difficile. Br J Hosp Med 1996;56:398-400.
34. Rosen L. Antibiotic-associated colitis. Perspect Colon Rectal Surg 1991;4:205-17.
35. Laughon BE, Viscidi RP, Gdovin SL, Yolken RH, Bartlett JG. Enzyme immunoassays for detection of Clostridium difficile toxins A and B in fecal specimens. J Infect Dis 1984;149:781-8.
36. Lipsett PA, Samantaray DK, Tam ML, Bartlett JG, Lillemoe KD. Pseudomembranous colitis; a surgical disease? Surgery 1994;116:491-6.
37. Pothoulakis C. Pathogenesis of Clostridium difficile-associated diarrhea. Eur J Gastroenterol Hepatol 1996;8:1041-47.
38. Trnka YM, Lamont JT. Clostridium difficile colitis. Adv Intern Med 1984;29:85-107.
39. Settle CD, Wilcox MH. Review article: antibiotic-induced Clostridium difficile infection. Aliment Pharmacol Ther 1996;10:835-41.
40. Borriello SP, Ketley JM, Mitchell TJ, et al. Clostridium difficile-a spectrum of virulence and analysis of putative virulence determinants in the hamster model of antibiotic-associated colitis. J Med Microbiol 1987;24:53-64.
41. Seddon SV, Hemingway, I, Borriello SP. Hydrolytic enzyme production by Clostridium difficile and its relationship to toxin production and virulence in the hamster model, J Med Microbiol 1990;31;169-74.
42. Dailey DC, Kaiser A, Schloemer RH. Factors influencing the phagocytosis of Clostridium difficile by human polymorphonuclear leukocytes. Infect Immun 1987;55:1541-6.
43. Kelly CP, Becker S, Linevsky JK, et al. Neutrophil recruitment in Clostridium difficile toxin A enteritis in the rabbit. J Clin Invest 1994;93:1257-65.
44. Chatila W, Manthous CA. Clostridium difficile causing sepsis and an acute abdomen in critically ill patients. Crit Care Med 1995;23:1146-50.
45. McCarter MD, Abularrage C, Velasco FT, Davis JM, Daly JM. Diarrhea and Clostridium difficile-associated diarrhea on a surgical service. Arch Surg 1996;131:1333-7.
46. McNeeley SG, Jr, Anderson GD, Sibai BM. Clostridium difficile colitis associated with single dose cefazolin prophylaxis. Obstet Gynecol 1985;66:737-38.
47. Kreisel D, Savel TG, Silver AL, Cunningham JD. Surgical antibiotic prophylaxis and Clostridium difficile toxin positivity. Arch Surg 1995;130:989-93.
48. Tedesco FJ. Pseudomembranous colitis: pathogenesis and therapy. Med Clin North Am 1982;66:655-64.
49. Triadafilopoulos G, Hallstone AE. Acute abdomen as the first presentation of pseudomembranous colitis. Gastroenterology 1991;101:685-91.
50. Burke GW, Wilson ME, Mehrez IO. Absence of diarrhea in toxic megacolon complicating Clostridium difficile pseudomembranous colitis. Am J Gastroenterol 1988;83:304-7.
51. Biddle WL, Harms JL, Greenberger NJ, Miner PR Jr. Evaluation of antibiotic-associated diarrhea with a latex agglutination test and cell culture cytotoxicity assay for Clostridium difficile. Am J Gastroenterol 1989;84:379-82.
52. Gerding DN. Diagnosis of Clostridium-difficile-associated disease: patient selection and test perfection. Am J Med 1996;100:485-6.
53. Arzese A, Trani G, Riul L, Botta GA. Rapid polymerase chain reaction method for specific detection of toxigenic Clostridium difficile. Eur J Clin Microbiol Infect Dis 1995;14:716-9.
54. Bartlett JG. Clostridium difficile: clinical considerations. Rev Infect Dis 1990;12(Suppl 2)43-51.
55. Morris JB, Zollinger RM Jr, Stellato TA. Role of surgery in antibiotic-induced pseudomembranous enterocolitis. Am J Surg 1990;160:535-9.
56. Church JM, Fazio VW. A role for colonic stasis in the pathogenesis of disease related to Clostridium difficile. Dis Colon Rectum 1986;29:804-9.
57. Seppala K, Hjelt L, Sipponen P. Colonoscopy in the diagnosis of antibiotic-associated colitis: a prospective study. Scand J Gastroenterol 1981;16:465-8.
58. Gerding DN, Brazier JS. Optimal methods for identifying Clostridium difficile infections. Clin Infect Dis 1993;16(Suppl 4):439-42.
59. Counihan TC, Roberts PL. Pseudomembranous colitis. Surg Clin North Am 1993;73:1063-74.
60. Dignan CR, Greenson JK. Can ischemic colitis be differentiated from C difficile colitis in biopsy specimens? Am J Surg Pathol 1997;21:706-10.
61. Ros PR, Buetow PC, Pantograg-Brown L, Forsmark CE, Sobin LH. Pseudomembranous colitis. Radiology 1996;198:1-9.
62. Fishman EK, Kavuru M, Jones B, et al. Pseudomembranous colitis: CT evaluation of 26 cases. Radiology 1991;180:57-60.
63. Cleary RK, Grossmann R, Fernandez FB, et al. Metronidazole may inhibit intestinal colonization with Clostridium difficile. Dis Colon Rectum 1998;41:464-7.
64. Johnson S, Homann SR, Bettin KM, et al. Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole: a randomized, placebo-controlled trial. Ann Intern Med 1992;117:297-302.
65. Pashby NL, Bolton RP, Sherriff RJ. Oral metronidazole in Clostridium difficile colitis. BMJ 1979;1:1605-6.
66. Fekety R, McFarland LV, Surawicz CM, Greenberg RN, Elmer GW, Mulligan ME. Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial. Clin Infect Dis 1997;24:324-33.
67. Schweitzer MA, Sweiss I, Silver DL, Stellato TA. The clinical spectrum of Clostridium difficile colitis in immunocompromised patients. Am Surg 1996;62:603-8.
68. Kleinfeld DI, Sharpe RJ, Donta ST. Parenteral therapy for antibiotic-associated pseudomembranous colitis [letter]. J Infect Dis 1988;157:389.
69. Freeman CD, Klutman NE, Lamp KC. Metronidazole: a therapeutic review and update. Drugs 1997;54:679-708.
70. Oliva SL, Guglielmo BJ, Jacobs R, Pons VG. Failure of intravenous vancomycin and intravenous metronidazole to prevent or treat antibiotic-associated pseudomembranous colitis. J Infect Dis 1989;159:1154-5.
71. Maggiolo F, Bianchi W, Ohnmeiss H. A new approach to the treatment of pseudomembranous colitis? J Infect Dis 1989;160:170-1.
72. Grundfest-Broniatowski S, Quader M, Alexander F, Walsh RM, Lavery I, Milsom J. Clostridium difficile colitis in the critically ill. Dis Colon Rectum 1996;39:619-23.
73. Teasley DG, Gerding DN, Olson MM, et al. Prospective, randomized trial of metronidazole versus vancomycin for Clostridium difficile-associated diarrhea and colitis. Lancet 1983;2:1043-6.
74. Wenisch C, Parschalk B, Hasenhundl M, Hirschl AM, Graninger W. Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea. Clin Infect Dis 1996;22:813-8.
75. Fekety R, Silva J, Kauffman C, Buggy B, Deery HG. Treatment of antibiotic-associated Clostridium difficile colitis with oral vancomycin: comparison of two dosage regimens. Am J Med 1989;86:15-9.
76. Wongwanich S, Kusum M, Phan-Urai R. Antibacterial activity of teicoplanin against Clostridium difficile. Southeast Asian J Trop Med Public Health 1996;27:606-9.
77. Bartlett JG. Clostridium difficile: History of its role as an enteric pathogen and the current state of knowledge about the organism. Clin Infect Dis 1994;18(Suppl 4):265-72.
78. Job ML, Jacobs NF Jr. Drug-induced Clostridium difficile-associated disease. Drug Saf 1997;17:37-46.
79. Young GP, Ward PB, Bayley N, et al. Antibiotic-associated colitis due to Clostridium difficile: double-blind comparison of vancomycin with bacitracin. Gastroenterology 1985;89:1038-45.
80. Salcedo J, Keates S, Pothoulakis C, et al. Intravenous immunoglobulin therapy for severe Clostridium difficile colitis. Gut 1997;41:366-70.
81. Hassett J, Meyers S, McFarland L, Mulligan ME. Recurrent Clostridium difficile infection in a patient with selective IgG1 deficiency treated with intravenous immune globulin and Saccharomyces boulardii. Clin Infect Dis 1995;20(Suppl 2):266-8.
82. Van Ness MM, Cattau EL Jr. Fulminant colitis complicating antibiotic-associated pseudomembranous colitis: case report and review of the clinical manifestations and treatment. Am J Gastroenterol 1987;82:374-7.
83. Tsutaoka B, Hansen J, Johnson D, Holodniy M. Antibiotic-associated pseudomembranous enteritis due to Clostridium difficile. Clin Infect Dis 1994;18:982-4.
84. Shortland JR, Spencer RC, Williams JL. Pseudomembranous colitis associated with changes in an ileal conduit. J Clin Pathol 1983;36:1184-7.
85. Testore GP, Nardi F, Babudieri S, Giuliano M, DiRosa R, Panichi G. Isolation of Clostridium difficile from human jejunum: identification of a reservoir for disease? J Clin Pathol 1986;39:861-2.
86. Schwan A, Sjolin S, Trottestam U, Aronsson B. Relaps-ing Clostridium difficile enterocolitis cured by rectal infusion of normal feces. Scand J Infect Dis 1984;16:211-5.
87. McFarland LV, Surawicz CM, Greenberg RN, et al Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo. Am J Gastroenterol 1995;90:439-48.
88. Biller JA, Katz AJ, Flores AF, Buie TM, Gorbach SL. Treatment of recurrent Clostridium difficile colitis with Lactobacillus GG. J Pediatr Gastroenterol Nutr 1995;21:224-6.
89. Seal D, Borriello SP, Barclay F, Welch A, Piper M, Bonnycastle M. Treatment of relapsing Clostridium difficile diarrhoea by administration of a non-toxigenic strain. Eur J Clin Microbiol Infect Dis 1987;6:51-3.
90. Boland GW, Lee MJ, Cats AM, Gaa JA, Saini S, Mueller PR. Antibiotic-induced diarrhea: specificity of abdominal CT for the diagnosis of Clostridium difficile disease. Radiology 1994;191:103-6.
91. Holmes NJ. Clostridium difficile colitis. Curr Surg 1996;53:16-9.
92. Rubin MS, Bodenstein LE, Kent KC. Severe Clostridium difficile colitis. Dis Colon Rectum 1995;38:350-4.
93. Trudel JL, Deschenes M, Mayrand S, Barkun AN. Toxic megacolon complicating pseudomembranous enterocolitis. Dis Colon Rectum 1995;38:1033-8.
94. Drapkin MS, Worthington MG, Chang TW, Razvi SA. Clostridium difficile colitis mimicking acute peritonitis. Arch Surg 1985;120:1321-2,
95. Reihner E, Hellers G, Lindqvist L, Veress B. Pseudomembranous colitis presenting as an acute abdomen. Eur J Surg 1996;162:579-81.
96. Yee HE Jr, Brown RS Jr, Ostroff JW. Fatal Clostridium difficile enteritis after total abdominal colectomy. J Clin Gastroenterol 1996;22:45-7.
97. Surawicz C. Clostridium difficile colitis: optimizing a cost-effective approach. Am J Gastroenterol 1996;91:1662-3.
98. Starr JM, Rogers TR, Impallomeni M. Hospital-acquired Clostridium difficile diarrhea and herd immunity. Lancet 1997;349:426-8.
99. Manian FA, Meyer L. CDAD rates [letter;comment]. Infect Control Hosp Epidemiol 1995;16:63-5.
100. Kaatz GW, Gitlin SD, Schaberg DR, et al. Acquisition of Clostridium difficile from the hospital environment. Am J Epidemiol 1988;127:1289-94.
101. Silva J Jr, Iezzi C. Clostridium difficile as a nosocomial pathogen. J Hosp Infect 1988;11(Suppl A):378-85.
102. Cartmill TD, Panigrahi H, Worsley, MA, et al. Management and control of a large outbreak of diarrhea due to Clostridium difficile. J Hosp Infect 1994;27:1-15.
103. Katz DA, Bates DW, Rittenberg E, et al. Predicting Clostridium difficile stool cytotoxin results in hospitalized patients with diarrhea. J Gen Intern Med 1997;12:57-62.
104. Larson E, Bobo L, Bennett R, et al. Lack of care giver hand contamination with endemic bacterial pathogens in a nursing home. Am J Infect Control 1992;20:11-5.
105. Dodson AP, Borriello SP. Clostridium difficile infection of the gut. J Clin Pathol 1996;49:529-32.
106. Ho M, Yang D, Wyle FA, Mulligan ME. Increased incidence of Clostridium difficile-associated diarrhea following decreased restriction of antibiotic use. Clin Infect Dis 1996;23(Suppl 1):102-6.
107. Naaber P, Lehto E, Salminen S, Mikelsaar M. Inhibition of adhesion of Clostridium difficile to caco-2 cells. FEMS Immunol Med Microbiol 1996;14:205-9.
108. Bartlett JG. Management of Clostridium difficile infection and other antibiotic-associated diarrheas. Eur J Gastroenterol Hepatol 1996;8:1054-61.
109. Kelly CP. Immune response to Clostridium difficile infection. Eur J Gastroenterol Hepatol 1996;8:1048-53,
110. Starr JM, Rogers TR, Impallomeni M. Hospital-acquired Clostridium difficile diarrhoea. Lancet 1997;349:1176-7.